Posted On: 12/01/2016 6:09:21 PM
Post# of 4
$BSTG secured Orphan status for its esophageal implant ahead of schedule; It has also updated its guidance - with is esophageal implant IND filing not targeted for Q3 '17 and going into human patients in Q4 '17.
(0)
(0)
Posts that I make on Investors Hangout reflect my own personal thinking and opinion and are neither endorsed nor approved by the subject companies, many of which may be clients or client prospects of our our NY-based investor relations consulting firm.
David Collins, Managing Director
Catalyst Global Investor Relations
www.catalyst-ir.com
dcc@catatalyst-ir.com
212 924 9800
David Collins, Managing Director
Catalyst Global Investor Relations
www.catalyst-ir.com
dcc@catatalyst-ir.com
212 924 9800
